CRISPR and Cas Genes Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Global CRISPR and Cas genes market is anticipated to grow at a CAGR of 13.5% during the forecast period (2023-2030). The technological advancements in CRISPR & Cas gene systems have contemporarily revolutionized the area of cancer research and therapeutics. As the prevalence of genetic diseases and complex medical conditions continues to rise, there is an increasing demand for innovative treatments that can target the root cause of these ailments. CRISPR-Cas systems are effective and effortlessly programmable nucleic acid-targeting tools. The use of CRISPR-Cas systems in bacterial activities, increase in research and development expenditure by governments in the fields of genome editing, rise in the presence of genetic diseases, and the use of CRISPR technology to advance crop production have been the key drivers of the CRISPR and Cas genes market globally.

Closed-end dsDNA enables researchers to perform gene knock-in with higher efficiency and lower toxicity than traditional PCR methods and is ideally suited for large-scale screening and scale-up in cell and gene therapy. In November 2021, GenScript Inc. launched the GenWand™ Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology-directed repair (HDR) templates in T-cell engineering. Non-viral vector delivery has clear advantages - including safety - in CRISPR/Cas applications for gene and cell therapy.

Antibody-targeted adeno-associated virus (AAV) vectors and delivery systems and proprietary Nme2 CRISPR/Cas9 (Nme2Cas9) systems adapted for viral vector delivery and designed to precisely modify a target gene. In October 2023, Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. collaborated to develop additional in vivo CRISPR-based gene editing therapies focused on neurological and muscular diseases. 

Various companies provide scientific objectives to decode all rejuvenation programs present in human cells, and to build an atlas of disease and rejuvenation targets for clinical translation. For instance, in August 2023, clock.bio launched to decode rejuvenation biology across the human genome. The company has developed an aging model that force-ages human induced pluripotent stem cells (hiPSCs) and triggers their self-rejuvenation mechanism. Unbiased CRISPR screens on large samples of these cells allow for the identification of gene candidates that are causally relevant for cell rejuvenation.

To Request a Sample of our Report on CRISPR and Cas Genes Market:  https://www.omrglobal.com/request-sample/crispr-and-cas-genes-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Product Type
By Service Type
By Application
By End Users

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Danaher Corp., GenScript Biotech, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Qiagen NV, and others. 

CRISPR and Cas Genes Market Report Segment

By Product Type

Vector-based Cas 
DNA-free Cas

By Service Type

Cell Line Engineering
gRNA design
Microbial Gene Editing
DNA Synthesis

By Application

Genome Engineering
Disease Models
Functional Genomics
Other (Biomedical)

By End Users

Biotechnology Companies & Pharmaceutical
Academic and Government Research Institute
CROs

A full Report of CRISPR and Cas Genes Market is Available @  https://www.omrglobal.com/industry-reports/crispr-and-cas-genes-market

CRISPR and Cas Genes Market Report Segment by Region

North America                                                                                                           

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America
Middle East and Africa 

Company Profiles

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/crispr-and-cas-genes-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.